U.S. Industrial REITs Stock News

HubSpot, trading as NYSE:HUBS, faces a shareholder proposal seeking the right for investors holding at least 10% of shares to call special meetings. The board has urged shareholders to vote against the proposal ahead of the upcoming annual shareholder meeting. The proposal focuses attention on investor rights and corporate governance practices at HubSpot. HubSpot enters this governance discussion with its shares at $225.97 and a value score of 4, which may catch the eye of investors...

With no single headline event driving Gilead Sciences (GILD) today, the focus shifts to how the stock’s recent performance, business mix and valuation metrics might inform your expectations for risk and return. See our latest analysis for Gilead Sciences. At a share price of $129.26, Gilead’s recent 1 month share price return of 5.19% and 90 day share price return of 7.37% contrast with a 1 year total shareholder return of 24.55% and 5 year total shareholder return of 134.15%. This suggests...

Alliance Resource Partners (ARLP) opened Q1 2026 with revenue of US$516 million and basic EPS of US$0.07, alongside trailing twelve month EPS of US$1.89 on revenue of about US$2.2 billion. This sets a clear snapshot of recent scale and earnings power. Over the past year, the partnership has seen quarterly revenue move between US$516 million and US$571 million, while basic EPS has ranged from US$0.07 to US$0.73, with trailing net profit margin sitting near 11.2%. For investors, that...

LifeStance Health Group (LFST) is drawing fresh interest after S&P Dow Jones Indices said the behavioral health provider will join the S&P SmallCap 600, prompting index tracking funds to start buying shares. See our latest analysis for LifeStance Health Group. The latest S&P SmallCap 600 announcement comes on top of a 22.92% 30 day share price return and a 16.74% 1 year total shareholder return. This suggests momentum has picked up recently even though longer term returns remain mixed. If...

If you are wondering whether DTE Energy is priced attractively right now, starting with what the current share price implies about value can help you frame your next move. The stock last closed at US$148.58, with returns of 3.6% over 7 days, 2.8% over 30 days, 14.0% year to date, 12.3% over 1 year, 47.6% over 3 years and 46.3% over 5 years, which gives you a clear snapshot of how the market has treated the shares across different timeframes. Recent headlines around DTE Energy have focused on...

Dell Technologies recently presented at Hannover Messe 2026 in Germany, while analysts highlighted growing demand for its AI-focused servers and infrastructure solutions. Together with a multi-billion-dollar AI infrastructure agreement and rising expectations for very large earnings growth, these developments underscore Dell’s expanding role in enterprise AI workloads. Next, we’ll examine how this accelerating AI infrastructure demand, including Dell’s large Boost Run agreement, may...

If you are wondering whether AGCO at around US$115 a share still offers value, you are not alone. Many investors are asking the same question right now. The stock has been uneven in the short term, with a 3.4% decline over the last week, a 1.5% gain over the last month, and returns of 8.9% year to date and 36.6% over the last year. Recent coverage has focused on AGCO's position in capital goods and agriculture equipment, as investors reassess companies tied to food production and farm...

Earlier this month, Sunoco LP announced a higher quarterly distribution of US$0.9899 per common unit (US$3.9596 annualized) for the March 31, 2026 quarter, a 6.25% increase over the prior quarter, payable on May 20, 2026 to holders of record on May 8, 2026. This distribution increase, coming alongside analyst expectations for materially higher near-term earnings, highlights how management is backing up a stronger operating outlook with higher cash returns to unitholders. We’ll now examine...

Calix (CALX) has drawn fresh attention after reporting first quarter revenue of US$279.98 million and net income of US$11.21 million. The company also increased its share repurchase authorization by US$100 million to US$525 million. See our latest analysis for Calix. Despite the increased buyback authorization and fresh quarterly numbers, Calix’s share price has come under pressure, with a 30 day share price return showing a 16.41% decline and a 90 day share price return showing a 20.64%...

In late April 2026, Procter & Gamble reported third-quarter fiscal 2026 results showing sales of US$21,235 million and net income of US$3,932 million, alongside reaffirmed full-year guidance for modest all-in sales and diluted EPS growth. These results, combined with P&G’s 70th consecutive annual dividend increase and ongoing product launches in categories like air care and haircare, underline how the company is pairing steady cash returns with continued brand innovation. With P&G’s earnings...

What Axalta’s Zencore Launch Means for Stock Watchers Axalta Coating Systems (AXTA) has introduced Zencore, a cabinet coating system that combines primer and enamel into one platform, aiming to simplify production for high volume manufacturers across North America. The launch focuses on reducing coating steps, SKU complexity, and rework while targeting consistent finish quality. This gives investors a fresh operational data point to consider alongside recent share price performance. See our...

In April 2026, Harmonic’s partners DIRECTV, NAGRAVISION and CentralCast announced deployments of Harmonic’s VOS Media Software and XOS Advanced Media Processor to streamline large-scale video workflows, cut operating costs and support higher-quality broadcast and streaming delivery. Together, these wins underscore how Harmonic’s cloud-native, API-driven and watermarking-enabled platforms are becoming embedded in critical broadcast and OTT infrastructure across pay-TV, public media and live...

Wondering whether TransUnion at around US$70 a share looks cheap, expensive, or somewhere in between? This article walks through the numbers so you can judge the price tag with more confidence. The stock is down about 9.5% over the last week and 15.9% year to date, while the 3 year return sits at 7.1%. These mixed figures can leave you questioning whether recent moves point to improving prospects or rising concerns. Recent headlines have focused on TransUnion as one of the major credit data...

Kimberly-Clark (KMB) opened 2026 with Q1 revenue of US$4.2 billion and basic EPS of US$1.70, setting a clear earnings-season marker for investors focused on both top and bottom line. Over the last six reported quarters, revenue has moved in a tight band between US$4.1 billion and US$4.2 billion, while quarterly basic EPS has ranged from roughly US$1.01 to US$1.70, giving a consistent view of how sales are translating into per share earnings. With trailing net profit margins lower than a year...

Recent share performance and business mix With no single headline event driving Azenta (AZTA), attention has turned to its recent share performance and business profile, especially after a month return of about 22% following weaker results over the past 3 months. The company focuses on biological and chemical compound sample exploration and management for life sciences customers, and splits its operations between Sample Management Solutions and Multiomics services. See our latest analysis for...

For readers wondering whether EchoStar's recent share price places it in bargain or stretched territory, this article breaks down what the numbers indicate about value. At a last close of US$123.70, EchoStar has recorded returns of 1.1% over 7 days, 10.2% over 30 days, 10.3% year to date and a 1 year gain of 450.3%, with a 3 year return of 661.2% and a 5 year return of 427.1%. Recent headlines around EchoStar have focused on its sharp share price move and what that implies for expectations...

If you are wondering whether Kenvue's current share price lines up with its underlying worth, this article walks through what the numbers are actually saying about value. Kenvue shares last closed at US$17.54, with returns of 1.4% over 7 days, 0.1% over 30 days, 1.3% year to date and a 21.8% decline over the past year. Recent coverage has focused on Kenvue's position as a standalone consumer health company following its separation from Johnson & Johnson and how investors are assessing the...

Wondering if Avantor's share price now reflects a bargain or just a value trap? This article breaks down what the current valuation signals really say. The stock recently closed at US$7.86, with returns of 6.1% over 30 days but a 31.4% decline year to date and a 38.1% decline over the past year. These moves can influence how the market views its risk and potential. Recent coverage has focused on Avantor's position within the broader life sciences tools and services space, where investor...

CRH (NYSE:CRH) is back in focus for investors after recent share price swings, with the stock showing a mix of short term declines and a gain over the past month. See our latest analysis for CRH. At the latest share price of $114.44, CRH has a 1 month share price return of 12.48%, while the year to date share price return of 9.49% and 1 year total shareholder return of 23.76% suggest momentum has recently picked up after earlier weakness. If you are comparing CRH with other materials and...

Artisan Partners Asset Management Inc. has reported past first-quarter 2026 results, with revenue rising to US$303.0 million from US$277.1 million a year earlier, while net income eased to US$58.0 million and diluted earnings per share from continuing operations slipped to US$0.76 from US$0.82. Alongside mixed earnings, the firm emphasized growing assets under management to US$173.0 billion, expanding into new strategies and teams, and highlighting industry recognition for its investment...

Investment context for Maze Therapeutics Maze Therapeutics (MAZE) has drawn investor attention after a period where the share price showed a 10.5% decline over the past month and a 42.3% decline over the past 3 months. Against that backdrop, the company’s clinical stage pipeline in kidney and metabolic diseases and its current financial profile, including a market value of about US$1.43b and a reported net loss of US$131.12 million, are front and center for investors assessing the stock...

Astera Labs (ALAB) is back in focus after strong Q4 2025 results, with revenue up 92% year over year and renewed attention on its role in AI data center connectivity. See our latest analysis for Astera Labs. That backdrop of strong Q4 numbers and high interest in AI data center hardware sits alongside a volatile share price, with a 62.99% 1 month share price return lifting year to date gains to 2.09%, while the 1 year total shareholder return is 179.22%. If you are watching AI infrastructure...

If you are wondering whether Inspire Medical Systems at around US$55.11 is now priced for a rebound or still carries valuation risk, the numbers offer some clear clues. The stock has moved 5.9% over the last 7 days and 9.9% over the last 30 days, but remains down 40.3% year to date and 65.5% over the past year. Recent coverage has focused on how a sharp pullback in the share price has reset expectations and drawn attention to the company’s long term growth story. That shift in attention is a...

On 22 April 2026, Coherent Corp. presented at AKL2026 in Germany, where leadership outlined the company’s position in the optical communications market and highlighted a base business estimated at US$50.00 billion. The CEO’s description of the current period as the “best time ever” for optical communications, alongside four higher-margin growth vectors adding over US$20.00 billion in incremental addressable market with defined revenue timelines, points to several potential expansion...